4362-0 |
Ofloxacin |
Mass |
Dose |
Pt |
Qn |
|
|
ACTIVE |
Ofloxacin [Mass] of Dose |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUGDOSE |
|
4362-0 |
|
|
|
|
Observation |
|
|
|
0 |
Ofloxacin Dose |
|
|
|
Y |
|
c409; Dose med or substance; DRUG DOSES; Floxin; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.69 |
1 |
|
|
|
|
|
|
|
mg |
|
|
|
0 |
43620-4 |
Actinomyces israelii Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Actinomyces israelii Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
43620-4 |
|
|
|
|
Both |
|
|
|
0 |
A israelii Ab Ser Ql |
|
|
|
N |
|
A israelii; ABS; Aby; Actino; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
43621-2 |
Actinomyces bovis Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Actinomyces bovis Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
43621-2 |
|
|
|
|
Both |
|
|
|
0 |
A bovis Ab Ser Ql |
|
|
|
N |
|
A bovis; ABS; Aby; Actino; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
43622-0 |
Aconitate |
PrThr |
Urine |
24H |
Ord |
|
|
ACTIVE |
Aconitate [Presence] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
43622-0 |
|
|
|
|
Both |
|
|
|
0 |
Aconitate 24h Ur Ql |
|
|
|
N |
|
1 day; 1-Propene-1,2,3-tricarboxylic acid; 24 hours; 24HR; Aconitic acid; Chemistry; Ordinal; PR; QL; Qual; Qualitative; Screen; UA; UR; Urn |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
43623-8 |
Acetylcholine receptor blocking Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Acetylcholine receptor blocking Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
43623-8 |
|
|
|
|
Both |
|
|
|
0 |
AChR Block Ab Ser Ql |
|
|
|
N |
|
ABS; Aby; Acetylch; ACH; AChR; AChR Block; ACRA; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Serum; SR |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
43624-6 |
Acetylcholine receptor binding Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Acetylcholine receptor binding Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
43624-6 |
|
|
|
|
Both |
|
|
|
0 |
AChR Bind Ab Ser Ql |
|
|
|
N |
|
ABS; Aby; Acetylch; ACH; AChR; AChR Bind; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bind; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Serum; SR |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
43625-3 |
Acetylcholine receptor Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Acetylcholine receptor Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
43625-3 |
|
|
|
|
Both |
|
|
|
0 |
AChR Ab Ser Ql |
|
|
|
N |
|
ABS; Aby; Acetylch; ACH; AChR; ACRA; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Serum; SR |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
43626-1 |
acetoHEXAMIDE |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Acetohexamide [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
43626-1 |
|
|
|
|
Both |
|
|
|
0 |
acetoHEXAMIDE SerPl Ql |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Dymelor; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
43627-9 |
acetaZOLAMIDE |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Acetazolamide [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
43627-9 |
|
|
|
|
Both |
|
|
|
0 |
acetaZOLAMIDE SerPl Ql |
|
|
|
N |
|
Acetadiazol; Acetazolam; AK-Zol; Diamox; DRUG/TOXICOLOGY; Drugs; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
43628-7 |
Acetaminophen crystals |
PrThr |
Urine sed |
Pt |
Ord |
Microscopy.light |
|
ACTIVE |
Acetaminophen crystals [Presence] in Urine sediment by Light microscopy |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
UA |
|
43628-7 |
|
Microscopy.light |
|
|
Observation |
|
|
|
0 |
Acetamin Cry UrnS Ql Micro |
|
|
|
N |
|
ACET; Acetamidophenol; Acetamin Cry; Acetaminoph; Acetominophen; APAP; c209; C55; Crys; Cryst; Crystal; Hydroxyacetanilide; Kidney; LM; Micro; Micros; Microscopic; N-(4-Hydroxyphenyl)acetanilide; N-Acetyl-p-aminophenol; Nephrology; Ordinal; p-Acetamidophenol; Paracetamol; p-Hydroxyacetanilide; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; Tylenol; u209; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
43629-5 |
8-Hydroxyamoxapine |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
8-Hydroxyamoxapine [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
43629-5 |
|
|
|
|
Both |
|
|
|
0 |
8OH-Amoxapine SerPl Ql |
|
|
|
N |
|
8-Hydroxy amoxapine; 8OH-Amoxapine; Amoxapine metabolite; DRUG/TOXICOLOGY; Drugs; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
4363-8 |
Orphenadrine |
Mass |
Dose |
Pt |
Qn |
|
|
ACTIVE |
Orphenadrine [Mass] of Dose |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUGDOSE |
|
4363-8 |
|
|
|
|
Observation |
|
|
|
0 |
Orphenadrine Dose |
|
|
|
Y |
|
Banflex; Biorphen; Brocasipal; Disipal; Dolan; Dose med or substance; DRUG DOSES; Flexon; Mephenamine; Myophen; Myotrol; Norflex; Norgesic; OrfenAce; Orphenadin; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.69 |
1 |
|
|
|
|
|
|
|
mg |
|
|
|
0 |
43630-3 |
6-Thioguanine |
PrThr |
RBC |
Pt |
Ord |
|
|
ACTIVE |
6-Thioguanine [Presence] in Red Blood Cells |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
43630-3 |
|
|
|
|
Both |
|
|
|
0 |
6-TGN RBC Ql |
|
|
|
N |
|
6-TG; 6-TGN; DRUG/TOXICOLOGY; Drugs; Erythrocytes; Lanvis; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen; TGN |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
43631-1 |
6-Methylmercaptopurine metabolite |
PrThr |
RBC |
Pt |
Ord |
|
|
ACTIVE |
6-Methylmercaptopurine metabolite [Presence] in Red Blood Cells |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
43631-1 |
|
|
|
|
Both |
|
|
|
0 |
6MMP metab RBC Ql |
|
|
|
N |
|
6-methyl-mercaptopurine; 6MMP; 6-MMP; 6MMP metab; DRUG/TOXICOLOGY; Drugs; Erythrocytes; Metab; Metabolites; Metb; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
43632-9 |
6-Methylmercaptopurine |
PrThr |
RBC |
Pt |
Ord |
|
|
ACTIVE |
6-Methylmercaptopurine [Presence] in Red Blood Cells |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
43632-9 |
|
|
|
|
Both |
|
|
|
0 |
6MMP RBC Ql |
|
|
|
N |
|
6-methyl-mercaptopurine; 6MMP; 6-MMP; DRUG/TOXICOLOGY; Drugs; Erythrocytes; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
43633-7 |
5-Oxoproline |
PrThr |
Urine |
24H |
Ord |
|
|
ACTIVE |
5-Oxoproline [Presence] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
43633-7 |
|
|
|
|
Both |
|
|
|
0 |
5Oxoproline 24h Ur Ql |
|
|
|
N |
|
1 day; 24 hours; 24HR; 5Oxoproline; Chemistry; Ordinal; Oxopro; Pidolate; Pidolic acid; PR; Pyroglutamate; Pyroglutamic acid; QL; Qual; Qualitative; Screen; UA; UR; Urn |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
43634-5 |
3-Methoxy-4-Hydroxyphenylglycol |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
3-Methoxy-4-Hydroxyphenylglycol [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
43634-5 |
|
|
|
|
Both |
|
|
|
0 |
3Me4OH-phenylglycol Ur Ql |
|
|
|
N |
|
3Me4OH-phenylglycol; Chemistry; III; MHPG; Norepinephrine metabolite; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn; Vanylglycol |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
43635-2 |
2-Hydroxyglutarate |
PrThr |
Urine |
24H |
Ord |
|
|
ACTIVE |
2-Hydroxyglutarate [Presence] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
43635-2 |
|
|
|
|
Both |
|
|
|
0 |
2OH-gluterate 24h Ur Ql |
|
|
|
N |
|
1 day; 24 hours; 24HR; 2-hydroxy-glutarate; 2-hydroxyglutaric acid; 2OH-gluterate; alpha-Hydroxyglutarate; alpha-Hydroxyglutaric acid; Chemistry; II; Ordinal; PR; QL; Qual; Qualitative; Screen; UA; UR; Urn |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
43636-0 |
Plasminogen activator tissue type |
PrThr |
PPP |
Pt |
Ord |
Chromo |
|
ACTIVE |
Plasminogen activator tissue type [Presence] in Platelet poor plasma by Chromogenic method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
COAG |
|
43636-0 |
|
Chromo |
|
|
Both |
|
|
|
0 |
tPA PPP Ql Chro |
|
|
|
N |
|
Blood plasminogen activator; Chromogenic assay; COAGULATION; ENZY; Enzymatic assay; Hematology; Heme; Ordinal; Plas; Platelet poor plasma; PLG; PLGN; Point in time; PR; Profibrinolysin; QL; Qual; Qualitative; Random; Screen; Tissue plasminogen activator; TPA; t-PA; Vascular plasminogen activator |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
43637-8 |
Parrot droppings Ab.IgG |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Parrot droppings IgG Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ALLERGY |
|
43637-8 |
|
|
|
|
Both |
|
|
|
0 |
Parrot Drop IgG Ql |
|
|
|
N |
|
ABS; Aby; African Gray Parrot; African Grey Parrot; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e98; Feces; Immune globulin G; Immunoglobulin G; Macaw; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; stool |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to Threshold to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
43638-6 |
Aquaporin 4 water channel Ab.IgG |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
43638-6 |
|
|
|
|
Both |
|
|
|
0 |
AQP4 H2O channel IgG SerPl Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; AQP4; AQP4 H2O channel; Autoantibodies; Autoantibody; Devic's disease; Immune globulin G; Immunoglobulin G; Neuromyelitis optica; NMO; NMO spectrum disorders; NMOSD; Opticospinal multiple sclerosis; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Water channel aquaporin-4 |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
Release 2.67: COMPONENT: Updated "receptor" to "water channel" per current scientific nomenclature; Previous Releases: The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
43639-4 |
Mercaptopurine |
PrThr |
Bld |
Pt |
Ord |
|
|
ACTIVE |
Mercaptopurine [Presence] in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
43639-4 |
|
|
|
|
Both |
|
|
|
0 |
Mercaptopurine Bld Ql |
|
|
|
N |
|
6-MP; Blood; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; Purinethol; QL; Qual; Qualitative; Random; Screen; WB; Whole blood |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
4364-6 |
Ouabain |
Mass |
Dose |
Pt |
Qn |
|
|
ACTIVE |
Ouabain [Mass] of Dose |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUGDOSE |
|
4364-6 |
|
|
|
|
Observation |
|
|
|
0 |
Ouabain Dose |
|
|
|
Y |
|
Acocantherin; Dose med or substance; DRUG DOSES; G-strophanthin; Point in time; Prostrophan; QNT; Quan; Quant; Quantitative; Random; Strodival; Ubaina |
2.69 |
1 |
|
|
|
|
|
|
|
mg |
|
|
|
0 |
43640-2 |
Aldosterone-18-glucuronide |
ACnc |
Urine |
Pt |
Qn |
|
|
DISCOURAGED |
Aldosterone-18-glucuronide [Units/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
43640-2 |
|
|
|
|
Both |
|
|
|
0 |
Aldost-18 G Ur-aCnc |
|
|
|
N |
|
Aldost-18 G; Aldosterone metabolite; Arbitrary concentration; Chemistry; Gluc; Glucouronide; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.69 |
2.17 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
43641-0 |
Views |
Find |
Lower extremity.left>Foot.sesamoid bones |
Pt |
Doc |
XR |
|
ACTIVE |
XR Foot sesamoid bones - left Views |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
43641-0 |
|
XR |
|
|
Both |
|
|
|
0 |
XR Ft.Sesamoids-L Views |
|
|
|
N |
|
Document; EXT; Extr-L; Films; Finding; Findings; Foot-L; Ft.Sesamoids-L; Imaging; L; LE; Leg; LE-L; LLE; Low; Lower extremity; LT; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Rad; RADIOLOGY; Random; View; VWS; Xray; X-ray |
2.64 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The scale has been changed from "Nar" to "Doc" to fit with the CDA model.; Updated System from "Foot.sesamoid bones.left" per LOINC/RadLex unified model |
0 |